| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8237509 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Sensorineural hearing loss is a late effect of CRT. In the absence of other factors, including ototoxic chemotherapy, increase in cochlear dose correlates positively with hearing loss in pediatric patients with brain tumor. To minimize the risk of hearing loss for children treated with radiation therapy, a cumulative cochlear dose less than 35 Gy is recommended for patients planned to receive 54-59.4 Gy in 30-33 treatment fractions.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chiaho Ph.D., Johnnie K. Au.D., Raja M.D., Larry E. M.D., Thomas E. D.O., Ph.D.,